News OECD calls for 'rebalancing of power' in drug price negotiat... Health systems should fund more treatments for chronic diseases, says EFPIA
News Pharma project aims to help doctors find drug info Industry giants such as AstraZeneca and Novartis are on board.
News NICE recommends Novartis kidney cancer drug Afinitor finally recommended after rejection in 2011.
News Novartis, BMS, Janssen unveil R&D deals Companies announce eye-catching R&D plans ahead of conference.
News Novartis faces bribery probe in Greece Prosecutors raid Athens offices, according to press reports.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
